Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cloxazolam | HCID 2816 | — |
| Reactant | Chloromethyl Methyl Ether | HCID 7864 | — |
| Reactant | Sodium Methoxide | HCID 10942334 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 21442401 | HCID 21442401 | — |
Reaction Steps
A solution of 2.8 g. of 10-chloro-11b-(2-chlorophenyl)-2,3, 5,11b-tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(7H)-one in 50 ml. of dimethylformamide was cooled to -10° and treated with 0.65 g. of sodium methoxide. After stirring for 5 minutes, the mixture was cooled to -40° and 1 ml. of chlorodimethyl ether was added. The cooling bath was removed and when the temperature had reached 0° the reaction mixture was poured into 300 ml. of ice-water. The precipitated material was collected by suction and dissolved in methylene chloride. The solution was dried over sodium sulfate, filtered and evaporated. The residue was crystallized from a mixture of ether and hexane to give, after recrystallization from ethanol, 10-chloro-11b-(2-chlorophenyl)-7-methoxymethyl-2,3,5,11b-tetrahydrooxazolo[3,2-d][1,4] benzodiazepin-6(7H)-one as white prisms, m.p. 14 4°-147°.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04017531 |
|---|
| Source dataset | uspto-grants-1977_04 |
|---|
| ORD ID | ord-53d4cf22af094dd5b1c60a92ef3c16ba |
|---|
| Source note | uspto-grants-1977_04 |
|---|